Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed Aug 14, 2026 · 10-Q · 45 days after period end · 0001493152-26-038509
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$5.76M | -$5.50M | -$9.66M | -$22.18M |
| EPS Diluted | -$1.52 | -$1.71 | -$0.04 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end
